Now, a research team has shown that a lab - made molecule that mimics an antibody from our immune system may have more protective power than anything the body produces, keeping four monkeys free of HIV infection despite injection of large
doses of the virus.
A small animal study suggests that high
doses of the virus, called adeno - associated virus 9, can cause severe liver and neuron damage in young monkeys and pigs.
«Previous studies have shown that antibody preparations that protect against low
doses of virus may be ineffective against higher doses,» they warn.
According to a report published today in the journal Nature, a team led by scientists from the National Institutes of Health (NIH) has developed a vaccine that protects monkeys from lethal
doses of the virus.
When people are exposed to high
doses of this virus, they can succumb as well.
Instead, you would have to start with a huge
dose of virus, says flu virologist Earl Brown of the University of Ottawa.
The researchers admit that they don't yet know whether these people actually developed symptoms of an infection and recovered or were exposed to a small
dose of the virus which they were able to fight off.
Scientists have created a designer protein that stops the influenza virus from infecting cells in culture and protects mice from getting sick after being exposed to a heavy
dose of the virus.
Doubling the time a bird can pass along a big
dose of virus could in theory increase the likelihood that a disease will spread.
The monkeys who were swabbed with the high
dose of virus encountered nearly 80,000 times the number of Zika particles the researchers counted in the saliva from the infected monkeys.
To further assess the effects of E-cig exposure on virus - induced mortality, mice were infected with a higher
dose of virus (103 TCID50).
FIP is much more likely to develop when there cats and kittens are challenged with a large
dose of virus.
The severity of clinical signs is also dependent upon
the dose of virus and specie of bacteria that infected a specific dog.
The severity of clinical symptoms is also dependent upon the exposure to the virus, i.e. duration and mode of contact with the infected dog and the ingested
dose of virus through direct or indirect transmission.
The first step of the project will be to determine an optimal and safe
dose of the virus for canine patients.
Not exact matches
GMOs are engineered with bacteria and
viruses to produce insecticides to survive heavy
doses of herbicides.
These babies need follow up tests and further
doses of vaccine against hepatitis B
virus at one month, two months and twelve months
of age for full protection.
less than or equal to lamivudine Acquired Immune Deficiency Syndrome Antiretroviral therapy, usually means 1 - 2 drugs, used in early studies Antiretroviral zidovudine (also known as ZDV) Breastfeeding Baby Friendly Hospital Initiative Breastfeeding and HIV International Transmission Study Combined antiretroviral therapy Centers for Disease Control and Prevention Deoxyribonucleic Acid Exclusive Breastfeeding Enzyme Linked Immunosorbent Assay Food and Agrigulture Organization Fixed
dose combination ART, e.g., lamividine, stavudine, and nevirapine Highly Active Antiretroviral Therapy, 3 or more drugs for more effective treatment used in later studies Human Immunodeficiency
virus International Atomic Energy Agency Infant feeding Infant and young child feeding Lopinavir cubic millimetre Mother - to - Child Transmission
of HIV Non-governmental organization Nevirapine Polymerase Chain Reaction People Living with HIV Prevention
of Mother - to - Child Transmission Replacement Feeding Ritonavir Ribonucleic acid, one
of the three major macromolecules (along with DNA and proteins) that are essential for all known forms
of life single
dose NVP United Nations Agencies Joint United Nations Programme on HIV / AIDS United Nations Population Fund United Nations Commissioner for Refugees United Nations Children's Fund U.S. Agency for International Development World Alliance for Breastfeeding Action United Nations World Food Programme World Health Assembly WHO 2010 Guidelines on HIV and infant feeding World Health Organization Zidovudine (same drug as AZT)
Research published in the October 21 issue
of Science Translational Medicine uses a
virus to deliver an extra
dose of the gene p11 to the adult mouse brain.
Polio is one
of those
viruses where you only need an incredibly small infectious
dose to get infected.
Full - scale production
of a vaccine that could prevent any illness at all from the strain would require at least three months after the
virus's emergence to begin, but it is hoped that vaccine production could increase until one billion
doses were produced by one year after the initial identification
of the
virus.
Data from in vivo mouse models indicate that delivery
of the DMAb sequence for the influenza A-targeted monoclonal antibody protected against lethal
doses of two very different, clinically relevant influenza A
viruses.
«It was not known whether any
of these vaccines could provide protection against the new outbreak West African Makona strain
of Ebola Zaire currently circulating in Guinea,» said John Eldridge, Chief Scientific Officer - Vaccines at Profectus Biosciences, Inc. «Our findings show that our candidate vaccines provided complete, single
dose protection from a lethal amount
of the Makona strain
of Ebola
virus.»
Unfortunately, this process is fraught with problems: It's slow (the eggs typically need to incubate for about half a year), inefficient (on average, it takes one to two eggs to yield a single
dose of vaccine), and unreliable: Not only can the eggs spoil, but they may also produce the
virus at varying rates.
While the individual effects
of the drugs on
virus - specific CTL differ somewhat depending on specific assays, schedules, and
doses, treatment with any
of the three HDAC inhibitors impaired the ability
of CTL to kill HIV - infected immune cells.
Not only were the mice protected from lethal
doses of flu
virus, but the protection was also in large part due to the absence
of familiar antibodies against the head, the researchers found.
Results from two studies in sub-Saharan Africa, simultaneously announced today, show for the first time that daily
doses of anti-HIV pills taken by uninfected men and women can prevent heterosexual transmission
of the
virus.
In August the U.S. government ordered millions
of doses of a live
virus vaccine.
A 12 - week
dose of an investigational three - drug hepatitis C combination cleared the
virus in 93 percent
of patients with liver cirrhosis who hadn't previously been treated, according to a study in the May 5, 2015, issue
of The Journal
of the American Medical Association.
«Our work so far suggests that this new vaccine strategy induces a level
of virus neutralization about 25 times greater, after a single
dose, than one sees in standard vaccines,» Weissman said.
Vaccine - mediated protection
of nonhuman primates against low
doses of cell - free HIV - 1, HIV - 2, or simian immunodeficiency
virus (SIV) has been demonstrated.
The first live - attenuated Zika vaccine still in the development stage completely protected mice against the
virus after a single vaccination
dose, according to new research from The University
of Texas Medical Branch at Galveston and Instituto Evandro Chagas at the Ministry
of Health in Brazil.
A tiny
dose of the proper, healthy RPE65 gene was inserted into a «gentle»
virus known as adeno - associated
virus (AAV), and the gene - carrying
virus was injected by Maguire into the retina
of one
of Cannata's eyes.
«A successful vaccine requires a fine balance between efficacy and safety — vaccines made from attenuated live
viruses generally offer fast and durable immunity, but sometimes with the trade - off
of reduced safety, whereas inactivated and subunit
viruses often provide enhanced safety but may require several
doses initially and periodic boosters.
Results from three Phase III clinical trials (ION - 1, ION - 2 and ION - 3) evaluating the investigational once - daily fixed -
dose combination
of the nucleotide analogue polymerase inhibitor sofosbuvir (SOF) 400 mg and the NS5A inhibitor ledipasvir (LDV) 90 mg, with and without ribavirin (RBV), for the treatment
of genotype 1 chronic hepatitis C
virus (HCV) infection have been presented at the International Liver CongressTM 2014.
Tests in macaque monkeys also showed that a single vaccine
dose of only 50 micrograms provided strong protection against exposure to Zika
virus five weeks later.
National Institutes
of Health (NIH) scientists report that a single
dose of an experimental Ebola
virus (EBOV) vaccine completely protects cynomolgus macaques against the current EBOV outbreak strain, EBOV - Makona, when given at least seven days before exposure, and partially protects them if given three days prior.
In Europe, which has yet to see sustained transmission in communities, four countries cut deals with GlaxoSmithKline to purchase more than 100 million
doses of a vaccine that targets the new H1N1
virus.
Each
of the volunteers was then administered an intranasal
dose (1 milliliter)
of 2009 H1N1 influenza
virus; the volunteers were required to stay in the study unit for nine days where they were monitored by medical staff 24 hours daily.
In its first test in humans, reported online October 4 in the New England Journal
of Medicine, one vaccine based on DNA from the
virus elicited an immune response, with 100 percent
of participants developing antibodies after a three -
dose regimen.
Researchers have identified the
dose of dengue
virus in human blood that is required to infect mosquitoes when they bite.
Mice vaccinated with the HIS
virus survived after being given lethal
doses of the flu, while most mice given saline instead
of HIS
virus died after exposure.
Mice vaccinated with the newly designed influenza
virus, called hyper - interferon - sensitive (HIS)
virus, survived exposure to lethal
doses of several different influenza A strains.
It has been known since 1960 that early
doses of polio vaccine were widely contaminated with simian
virus 40, or SV40, which infects macaque monkeys.
In previous human challenge trials with this modified
virus, Dr. Whitehead and his coinvestigators established the
virus dose that would cause all recipients to develop viremia — the presence
of virus in the blood — and most to develop a mild rash.
Lower dosages did not generate responses that met this threshold, thereby establishing the minimum
dose of influenza
virus needed to produce mild - to - moderate illness.
Led by Bavari and Travis Warren, Ph.D., the USAMRIID team performed a series
of studies involving a lethal challenge with Marburg
virus in nonhuman primates to determine the efficacious
dose and regimen
of AVI - 7288, as well as to characterize the drug exposures in animals that produced efficacy.
Two days after infecting groups
of guinea pigs with a lethal
dose of Lassa
virus, the scientists treated the rodents daily for two weeks with either ribavirin, low
doses of favipiravir, or high
doses of favipiravir.
But the drug combines low
doses of two antiretroviral agents normally used to treat infection, and some researchers fear that its use in healthy people could have unacceptable side effects and spark the emergence
of resistant
viruses.
But the Congolese government, worried that the
virus could spread rapidly among Kinshasa's 10 million residents, has decided to stretch the 1.7 million
doses it has received by giving people 0.1 milliliters
of the vaccine each instead
of the standard 0.5 milliliters.